Company intelligence / Profile preview

REMSleep Holdings

Clearwater, Florida, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

REMSleep Holdings' DELTAWAVE Nasal Pillows System, an advanced CPAP interface, has received FDA 510(k) clearance and is marketed for improving patient compliance and comfort in the treatment of obstructive sleep apnea. The company focuses on innovation in CPAP device interfaces but has not published results from traditional pharmaceutical clinical trials.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on REMSleep Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on REMSleep Holdings.

Explore the full profile